FGFR2 and cancer: KGF was localized in the cytoplasm of cancer cells in 27 of 63 (42.9%) patients (Fig. 2A), while KGFR immunoreactivity was detected in the cytoplasm and/or cell membrane of cancer cells in 23 of 63 (36.5%) patients (Fig. 2B).